Sir Charles Gairdner Hospital
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 1958-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
88
Active:3
Completed:26
Trial Phases
5 Phases
Phase 1:5
Phase 2:10
Phase 3:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (83 trials with phase data)• Click on a phase to view related trials
Not Applicable
58 (69.9%)Phase 2
10 (12.0%)Phase 4
7 (8.4%)Phase 1
5 (6.0%)Phase 3
3 (3.6%)Topical Magnesium and Muscle Cramps in Dialysis Patients.
Phase 2
- Conditions
- Chronic Kidney DiseasesEnd Stage Renal DiseaseDialysis Related Complications
- Interventions
- Drug: Transdermal MagnesiumDrug: Placebo
- First Posted Date
- 2017-03-17
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- Sir Charles Gairdner Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03082625
Catheter Over Needle vs Catheter Through Needle
Phase 4
Completed
- Conditions
- Nerve BlockCatheterization
- First Posted Date
- 2015-05-01
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Sir Charles Gairdner Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT02431858
- Locations
- 🇦🇺
Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients
Phase 1
Terminated
- Conditions
- Peritoneal Dialysis, Continuous AmbulatoryPeritoneal Dialysis
- Interventions
- Drug: Tissue Plasminogen Activator (tPA)
- First Posted Date
- 2011-11-23
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Sir Charles Gairdner Hospital
- Target Recruit Count
- 5
- Registration Number
- NCT01478698
- Locations
- 🇦🇺
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients
Phase 4
Completed
- Conditions
- End Stage Kidney Disease
- Interventions
- First Posted Date
- 2008-11-27
- Last Posted Date
- 2013-06-10
- Lead Sponsor
- Sir Charles Gairdner Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT00798993
- Locations
- 🇦🇺
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
Completed
- Conditions
- Kidney Failure, ChronicAnemia
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2008-05-23
- Lead Sponsor
- Sir Charles Gairdner Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT00382044
- Locations
- 🇦🇺
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
- Prev
- 1
- 2
- Next
News
No news found